

Patient must be prescribed Afrezza (insulin human) Inhalation Powder. Terms and Conditions for Copay Offer: Pay as little as $35 for Afrezza® per month, up to a maximum savings of $2000.
AIMOVIG COPAY CARD FULL
See full Terms and Conditions below.īy participating in the Afrezza Savings Card program, you acknowledge that you are an eligible patient, age 18 years or older, and that you understand and agree to comply with the terms and conditions of this offer, as described in further detail below. If coverage for Afrezza (insulin human) Inhalation Powder is approved by the patient’s health plan, a patient can qualify for the Copay Offer and pay as little as $35 per fill (saving as much as $2000 per month), up to a maximum of 12 fills annually. With the Afrezza® Savings Card, an eligible, commercially-insured patient age 18 years and older can receive this Copay Offer, see details below. You may report side effects to FDA at 1-80 (1-80). These are not all the possible side effects of Afrezza®. Call your doctor for medical advice about side effects.


There were too few cases to know if lung cancer was related to Afrezza®. Lung cancer. In studies of Afrezza® in people with diabetes, lung cancer occurred in a few more people who were taking Afrezza® than in people who were taking other diabetes medications.Decreased lung function. Your healthcare provider should check how your lungs are working before you start using Afrezza®, 6 months after you start using it and yearly after that.Dizziness or light-headedness, sweating, confusion, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability or mood change, hunger.Signs and symptoms that may indicate low blood sugar include: See “What is the most important information I should know about Afrezza®?” at the top of this page. Accessed on December 14, 2022.Īfrezza® may cause serious side effects that can lead to death, including: Saving money with the Inflation Reduction Act.Afrezza® (insulin human) Inhalation Powder Prescribing Information.See full Program Terms, Conditions, and Eligibility Criteria. This applies to patient out-of-pocket costs, including deductible, co-insurance, and copayments for Afrezza®. If approved by the patient’s health plan to take Afrezza®, a patient will pay as little as $35 per month.

If the patient’s health plan does not cover Afrezza® or requires a prior authorization, contact AfrezzaAssist℠ for more information. Maximum savings limit applies patient out-of-pocket expense may vary. It is not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs. This offer is available for patients with commercial drug insurance coverage. If you haven’t met your deductible, you’ll see higher prices until the deductible is met, then your out-of-pocket cost will likely drop. Each plan has different preferred drug lists and out-of-pocket amounts, and most include an annual deductible. *What you pay for Afrezza® will depend on your insurance plan.
